±¹¼Ò ÇǺΠÀÚ¹ÝÀÇ ÇüÅ·Π³ªÅ¸³­ ½ÄÇ÷¼¼Æ÷¼º ¸²ÇÁÁ¶Á÷±¸Áõ 1¿¹
Hemophagocytic Lymphohistiocytosis Manifesting as a Purpuric Patch

´ëÇÑÇǺΰúÇÐȸÁö 2014³â 52±Ç 6È£ p.421 ~ p.424

·ù¼Ò¹Î(Lyu So-Min) - ÀÌÈ­¿©ÀÚ´ëÇб³ ÀÇÇÐÀü¹®´ëÇпø ÇǺΰúÇб³½Ç
º¯Áö¿¬(Byun Ji-Yeon) - ÀÌÈ­¿©ÀÚ´ëÇб³ ÀÇÇÐÀü¹®´ëÇпø ÇǺΰúÇб³½Ç
ÃÖÀ¯¿ø(Choi You-Won) - ÀÌÈ­¿©ÀÚ´ëÇб³ ÀÇÇÐÀü¹®´ëÇпø ÇǺΰúÇб³½Ç
ÃÖÇý¿µ(Choi Hae-Young) - ÀÌÈ­¿©ÀÚ´ëÇб³ ÀÇÇÐÀü¹®´ëÇпø ÇǺΰúÇб³½Ç

Abstract

Hemophagocytic lymphohistiocytosis (HLH) is a fatal, systemic inflammatory syndrome that characteristically presents hemophagocytic histiocytes infiltrating into various organs. Common features of HLH are abrupt onset of high fever, malaise, lymphadenopathy, hepatosplenomegaly, and abnormal laboratory findings including pancytopenia, hypertriglyceridemia, hypofibrinogenemia, and high ferritin levels. Cutaneous manifestations, which occur in 6¡­65% of patients, can develop at any moment in the clinical course of the syndrome. Most skin eruptions in HLH patients are generalized, transient maculopapular rashes. We describe an HLH patient who first manifested cutaneous symptoms as a large purpuric patch on her thigh. A skin biopsy found high levels of hemophagocytic histiocytes.

Å°¿öµå

Hemophagocytic lymphohistiocytosis, Purpura
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø 
ÁÖÁ¦ÄÚµå
ÁÖÁ¦¸í(Target field)
¿¬±¸´ë»ó(Population)
¿¬±¸Âü¿©(Sample size)
´ë»ó¼ºº°(Gender)
Áúº´Æ¯¼º(Condition Category)
¿¬±¸È¯°æ(Setting)
¿¬±¸¼³°è(Study Design)
¿¬±¸±â°£(Period)
ÁßÀç¹æ¹ý(Intervention Type)
ÁßÀç¸íĪ(Intervention Name)
Å°¿öµå(Keyword)
À¯È¿¼º°á°ú(Recomendation)
¿¬±¸ºñÁö¿ø(Fund Source)
±Ù°Å¼öÁØÆò°¡(Evidence Hierarchy)
ÃâÆdz⵵(Year)
Âü¿©ÀúÀÚ¼ö(Authors)
´ëÇ¥ÀúÀÚ
DOI
KCDÄÚµå
ICD 03
°Ç°­º¸ÇèÄÚµå